After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, RVMD falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Revolution Medicines Inc is $5.85B. A total of 1.12 million shares were traded on the day, compared to an average of 1.44M shares.
In the most recent transaction, GOLDSMITH MARK A sold 10,000 shares of RVMD for 35.33 per share on Apr 10 ’24. After the transaction, the insider now owns 30,424 company shares. In a previous transaction on Apr 10 ’24, GOLDSMITH MARK A sold 7,500 shares at 35.48 per share. RVMD shares that the insider owns now total 452,879.
Among the insiders who sold shares, Patel Sushil disposed of 2,155 shares on Apr 10 ’24 at a per-share price of $37.00. This resulted in the Director holding 15,700 shares of RVMD after the transaction. In another insider transaction, Cislini Jeff sold 1,500 shares at $30.99 per share on Mar 27 ’24. Company shares held by the General Counsel now total 54,374.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, RVMD has a high of $38.73 and a low of $15.44.
As of this writing, RVMD has an earnings estimate of $Revolution Medicines, Inc. per share for the current quarter. EPS was calculated based on a consensus of ResMed Inc. estimates, with a high estimate of $PROGRESSIVE CARE INC per share and a lower estimate of $Relmada Therapeutics, Inc..
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. RVMD’s latest balance sheet shows that the firm has $577.05M in Cash & Short Term Investments as of fiscal 2021. There were $66.63M in debt and $60.35M in liabilities at the time. Its Book Value Per Share was $11.09, while its Total Shareholder’s Equity was $602.57M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RVMD is Buy with a score of 4.92.
